Ignite Creation Date:
2024-05-05 @ 4:59 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00368875
Status:
COMPLETED
Last Update Posted:
2015-11-05
First Post:
2006-08-24
Brief Title:
Phase I-II Study of Vorinostat Paclitaxel and Bevacizumab in Metastatic Breast Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Male Breast Cancer |
| Stage IIIB Breast Cancer |
| Stage IIIC Breast Cancer |
| Stage IV Breast Cancer |
Keywords: